13
Views
4
CrossRef citations to date
0
Altmetric
REVIEW OF A SCANDINAVIAN THESIS

Recombinant human erythropoietin: experimental and clinical applications

Pages 1-10 | Published online: 26 Feb 2018

REFERENCES

  • Groopman JE, Molina J-M, Scadden DT. Hematopoietic growth factors. N Engl J Med 1989; 321: 1449–59.
  • Erslev AJ. Humoral regulation of red cell production. Blood 1953; 8: 349–57.
  • Jacobson LO, Goldwasser E, Fried W, Plzak L. Role of the kidney in erythropoiesis. Nature 1957; 170: 633–4.
  • Erslev AJ. In vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood 1974; 44: 77–85.
  • Miyake T, Kung CK-H, Goldwasser E, Plzak L. Purification of human erythropoietin. J Biol Chem 1977; 252: 5558–64.
  • Jacobs K, Shoemaker C, Rudersdorf SD et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806–9.
  • Nielsen OJ, Costa-Gioma P, Weinmann R et al. Erythropoietin-β-D-galactosidase. The generation, purification and use of a fusion protein. J Immunol Methods 1988; 111: 1–9.
  • Shoemaker CB, Mitsock LD. Murine erythropoietin gene, cloning, expression and human gene homology. Mol Cel Biol 1986; 6: 849–58.
  • Semenza GL, Dureza RC, Traystman MD et al. Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol Cel Biol 1990; 10: 930–8.
  • Recny MA, Scoble HA, Kim Y. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. J Biol Chem 1987; 262: 17156–63.
  • Dordal MS, Wang FF, Goldwasser E. The role of carbohydrate in erythropoietin action. Endocrinology 1985; 116: 2293–9.
  • Wang FF, Kung CK-H, Goldwasser E. Some chemical properties of human EPO. Endocrinology 1985; 116: 2286–92.
  • Nielsen OJ, Egfjord M, Hirth P. Erythropoietin metabolism in the isolated perfused rat liver. In: Baldamus CA, Scigalla P, Wieczorek L et al., eds. Erythropoietin: from Molecular Structure to Clinical Application. Basel: Contributions to Nephrology 1989; 76: 90–7.
  • Nielsen OJ, Schuster SJ, Kaufman R et al. Regulation of erythropoietin production in a human hepatoblastoma cell line. Blood 1987; 70: 1904–9.
  • Dubé S, Fisher JW, Powell JS. Glycosylation at specific sites of erythropoietin is essential for the biosynthesis, secretion, and biological function. J Biol Chem 1988; 263: 17156–521.
  • Garcia JF, Sherwood J, Goldwasser E. Radioimmunoassay of erythropoietin. Blood Cells 1979; 5: 405–19.
  • Egrie JC, Cotes PM, Lane J et al. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin both as tracer and immunogen. J Immunol Methods 1987; 99: 235–41.
  • Nielsen OJ. Determination of human erythropoietin by radioimmunoassay. Method and clinical data. Clinica Chimica Acta 1988; 176: 303–14.
  • Erslev AJ, Wilson J, Caro J. Erythropoietin titres in anaemic, non uraemic patients. J Lab Clin Med 1987; 109: 429–33.
  • Caro J, Erslev AJ. Biological and immunological erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions. J Lab Clin Med 1984; 103: 922–31.
  • Lacombe C, DaSilva J-L, Bruneval P et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988; 81: 620–3.
  • Koury MJ, Koury ST, Bondurant MC. Correlation of the molecular and anatomical aspects of renal erythropoietin production. In: Baldamus CA, Scigalla P, Wieczorek L et al., eds. Erythropoietin: from Molecular Structure to Clinical Application. Basel: Contributions to Nephrology 1989; 76: 24–32.
  • Jelkmann W. Temporal pattern of erythropoietin titers in kidney tissue during hypoxic hypoxia. Pflügers Arch 1982; 393: 88–91.
  • Goldberg MA, Dunning SP, Bunn HB. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 1988; 242: 1412–5.
  • Nielsen OJ, Thaysen JH. Erythropoietin deficiency in acute tubular necrosis. J Int Med 1990; 227: 373–80.
  • McDougall I, Neubert P, Coles GA. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet 1989; ii: 425–7.
  • Nielsen OJ. Pharmacokinetics of recombinant human erythropoietin in chronic hemodialysis patients. Pharmacol Toxicol 1990; 66: 83–6.
  • Emmanouel DS, Goldwasser E, Metabolism of pure human erythropoietin in the rat. Am J Physiol 1984; 247: F168–76.
  • Sawyer ST, Bozzini CE. Influence of the erythroid activity of the bone marrow on the plasma disappearance of injected erythropoietin in dogs. Nature 1966; 209: 1140–2.
  • Nielsen OJ, Egfjord M, Hirth P. Metabolism of recombinant erythropoietin in the isolated perfused rat liver. Liver 1990 (in press).
  • Erslev AJ, Anemia of chronic renal failure. In: Williams WJ, Beutler E. Erslev AJ et al. (eds). Hematology 3rd edn. New York: McGraw-Hill 1983b; 417–25.
  • Radtke HW, Claussner A, Erbes PM et al. Serum erythropoietin concentrations in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54: 877–84.
  • Segal GM, Eshbach JW, Egrie JC et al. The anemia of end-stage renal disease: progenitor cell response. Kidney Int 1988; 33: 983–8.
  • Wallie AJ, Wong GY, Clemons GK et al. Erythropoietin—hematocrit feedback circuit in the anemia of end-stage renal disease. Kidney Int 1987; 31: 1205–9.
  • Nielsen OJ, Thaysen JH. Erythropoietin deficiency in acute renal failure. Lancet 1990; i: 624–5.
  • Lee GR. The anemia of chronic disorders. Seminars in Hematology 1983; 20: 61–79.
  • Birgegård G, Hällgren R, Caro J. Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anemia and the effect of anti-inflammatory treatment. Br J Haematol 1987; 65: 479–84.
  • Nielsen OJ, Andersen LS, Ludwigsen E et al. The anemia of rheumatoid arthritis. Serum erythropoietin levels and red cell distribution width in relation to iron status. Annals of the Rheumatic Diseases 1990b; 49: 349–53.
  • Means RT, Olsen NJ, Krantz SB et al. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis and Rheumatism 1989; 32: 638–42.
  • Nielsen OJ, Brandt M, Drivsholm A. The secretory EPO response in patients with multiple myeloma and Morbus Waldenström. Scand J Clin Lab Invest 1990; 50: 697–703.
  • Nielsen OJ, Thaysen JH. Response to erythropoietin in anaemic hemodialysis patients with iron overload. J Int Med 1989; 226: 89–94.
  • Eshbach JW, Egrie JC, Downing RM et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–7.
  • Granolleros C, Branger B, Beau MC, Deschoot G, Alsabadani B, Shaldon S. Experience with self-administered subcutaneous erythropoietin. In: Baldamus CA, Scigalla P, Wieczorek L, Koch KM. Erythropoietin: from Molecular Structure to Clinical Application. Basel: Contributions to Nephrology 1989; 76: 143–8.
  • Garcia DL, Anderson S, Rennke HG et al. Anemia lessens and its prevention worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988; 85: 6142–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.